Disrupting of IGF2BP3-stabilized CLDN11 mRNA by TNF-α increases intestinal permeability in obesity-related severe acute pancreatitis

Abstract Background Obesity is a significant risk factor for severe acute pancreatitis (SAP) and is typically associated with increased intestinal permeability. Understanding the role of specific molecules can help reduce the risk of developing SAP. Claudin 11 (CLDN11), a member of the Claudin famil...

Full description

Saved in:
Bibliographic Details
Main Authors: Lihui Lin, Yansong Lin, Xianwen Guo, Ruoyi Zhang, Xin Ling, Zewen Zhang, Rong Lin, Zhen Ding
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Molecular Medicine
Subjects:
Online Access:https://doi.org/10.1186/s10020-025-01078-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585626188251136
author Lihui Lin
Yansong Lin
Xianwen Guo
Ruoyi Zhang
Xin Ling
Zewen Zhang
Rong Lin
Zhen Ding
author_facet Lihui Lin
Yansong Lin
Xianwen Guo
Ruoyi Zhang
Xin Ling
Zewen Zhang
Rong Lin
Zhen Ding
author_sort Lihui Lin
collection DOAJ
description Abstract Background Obesity is a significant risk factor for severe acute pancreatitis (SAP) and is typically associated with increased intestinal permeability. Understanding the role of specific molecules can help reduce the risk of developing SAP. Claudin 11 (CLDN11), a member of the Claudin family, regulates the permeability of various internal barriers. However, the role and mechanism of CLDN11 in the intestinal permeability of obesity-related SAP remain unclear. Methods We evaluated intestinal permeability and the expression of CLDN11 in experimental obesity-related SAP. A recombinant adeno-associated virus carrying CLDN11 was used to treat experimental obesity-related SAP. The interaction between CLDN11 mRNA and insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) protein was predicted through bioinformatics analysis and validated by RNA immunoprecipitation and RNA pull-down assay. Additionally, tumor necrosis factor-α (TNF-α) treatment in Caco-2 cells was conducted, and the IGF2BP3/CLDN11 axis was detected. Moreover, we conducted anti-TNFα therapy and evaluated intestinal permeability and pancreatic inflammation in experimental obesity-related SAP. Results Downregulation of CLDN11 was observed in the intestinal epithelial cells of experimental obesity-related SAP. When the expression of CLDN11 in intestinal epithelial cells of experimental obesity-related SAP was increased exogenously, intestinal epithelial permeability and pancreatic inflammation were relieved. Overexpression of CLDN11 reduced the paracellular permeability of Caco-2 monolayer cells, while knockdown of CLDN11 increased it. IGF2BP3 bound to and regulated the stability of CLDN11 mRNA. TNF-α treatment downregulated IGF2BP3 and CLDN11 in vitro. Anti-TNFα therapy reduced intestinal permeability, alleviated pancreatitis, and improved the expression of IGF2BP3 and CLDN11 in intestinal epithelial cells in experimental obesity-related SAP. Conclusion CLDN11 regulates intestinal permeability in obesity-related SAP. Mechanistically, an increase in TNF-α impaired the stability of IGF2BP3-dependent CLDN11 mRNA in obesity-related SAP.
format Article
id doaj-art-3797501c6a3542fba0698b004c6e80f1
institution Kabale University
issn 1528-3658
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Molecular Medicine
spelling doaj-art-3797501c6a3542fba0698b004c6e80f12025-01-26T12:38:40ZengBMCMolecular Medicine1528-36582025-01-0131111710.1186/s10020-025-01078-9Disrupting of IGF2BP3-stabilized CLDN11 mRNA by TNF-α increases intestinal permeability in obesity-related severe acute pancreatitisLihui Lin0Yansong Lin1Xianwen Guo2Ruoyi Zhang3Xin Ling4Zewen Zhang5Rong Lin6Zhen Ding7Division of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen UniversityDepartment of Pathology, Sun Yat-Sen University Cancer CenterDivision of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen UniversityDivision of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen UniversityDivision of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen UniversityDivision of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen UniversityDepartment of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDivision of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen UniversityAbstract Background Obesity is a significant risk factor for severe acute pancreatitis (SAP) and is typically associated with increased intestinal permeability. Understanding the role of specific molecules can help reduce the risk of developing SAP. Claudin 11 (CLDN11), a member of the Claudin family, regulates the permeability of various internal barriers. However, the role and mechanism of CLDN11 in the intestinal permeability of obesity-related SAP remain unclear. Methods We evaluated intestinal permeability and the expression of CLDN11 in experimental obesity-related SAP. A recombinant adeno-associated virus carrying CLDN11 was used to treat experimental obesity-related SAP. The interaction between CLDN11 mRNA and insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) protein was predicted through bioinformatics analysis and validated by RNA immunoprecipitation and RNA pull-down assay. Additionally, tumor necrosis factor-α (TNF-α) treatment in Caco-2 cells was conducted, and the IGF2BP3/CLDN11 axis was detected. Moreover, we conducted anti-TNFα therapy and evaluated intestinal permeability and pancreatic inflammation in experimental obesity-related SAP. Results Downregulation of CLDN11 was observed in the intestinal epithelial cells of experimental obesity-related SAP. When the expression of CLDN11 in intestinal epithelial cells of experimental obesity-related SAP was increased exogenously, intestinal epithelial permeability and pancreatic inflammation were relieved. Overexpression of CLDN11 reduced the paracellular permeability of Caco-2 monolayer cells, while knockdown of CLDN11 increased it. IGF2BP3 bound to and regulated the stability of CLDN11 mRNA. TNF-α treatment downregulated IGF2BP3 and CLDN11 in vitro. Anti-TNFα therapy reduced intestinal permeability, alleviated pancreatitis, and improved the expression of IGF2BP3 and CLDN11 in intestinal epithelial cells in experimental obesity-related SAP. Conclusion CLDN11 regulates intestinal permeability in obesity-related SAP. Mechanistically, an increase in TNF-α impaired the stability of IGF2BP3-dependent CLDN11 mRNA in obesity-related SAP.https://doi.org/10.1186/s10020-025-01078-9ObesitySevere acute pancreatitisIntestinal permeabilityCLDN11IGF2BP3TNF-α
spellingShingle Lihui Lin
Yansong Lin
Xianwen Guo
Ruoyi Zhang
Xin Ling
Zewen Zhang
Rong Lin
Zhen Ding
Disrupting of IGF2BP3-stabilized CLDN11 mRNA by TNF-α increases intestinal permeability in obesity-related severe acute pancreatitis
Molecular Medicine
Obesity
Severe acute pancreatitis
Intestinal permeability
CLDN11
IGF2BP3
TNF-α
title Disrupting of IGF2BP3-stabilized CLDN11 mRNA by TNF-α increases intestinal permeability in obesity-related severe acute pancreatitis
title_full Disrupting of IGF2BP3-stabilized CLDN11 mRNA by TNF-α increases intestinal permeability in obesity-related severe acute pancreatitis
title_fullStr Disrupting of IGF2BP3-stabilized CLDN11 mRNA by TNF-α increases intestinal permeability in obesity-related severe acute pancreatitis
title_full_unstemmed Disrupting of IGF2BP3-stabilized CLDN11 mRNA by TNF-α increases intestinal permeability in obesity-related severe acute pancreatitis
title_short Disrupting of IGF2BP3-stabilized CLDN11 mRNA by TNF-α increases intestinal permeability in obesity-related severe acute pancreatitis
title_sort disrupting of igf2bp3 stabilized cldn11 mrna by tnf α increases intestinal permeability in obesity related severe acute pancreatitis
topic Obesity
Severe acute pancreatitis
Intestinal permeability
CLDN11
IGF2BP3
TNF-α
url https://doi.org/10.1186/s10020-025-01078-9
work_keys_str_mv AT lihuilin disruptingofigf2bp3stabilizedcldn11mrnabytnfaincreasesintestinalpermeabilityinobesityrelatedsevereacutepancreatitis
AT yansonglin disruptingofigf2bp3stabilizedcldn11mrnabytnfaincreasesintestinalpermeabilityinobesityrelatedsevereacutepancreatitis
AT xianwenguo disruptingofigf2bp3stabilizedcldn11mrnabytnfaincreasesintestinalpermeabilityinobesityrelatedsevereacutepancreatitis
AT ruoyizhang disruptingofigf2bp3stabilizedcldn11mrnabytnfaincreasesintestinalpermeabilityinobesityrelatedsevereacutepancreatitis
AT xinling disruptingofigf2bp3stabilizedcldn11mrnabytnfaincreasesintestinalpermeabilityinobesityrelatedsevereacutepancreatitis
AT zewenzhang disruptingofigf2bp3stabilizedcldn11mrnabytnfaincreasesintestinalpermeabilityinobesityrelatedsevereacutepancreatitis
AT ronglin disruptingofigf2bp3stabilizedcldn11mrnabytnfaincreasesintestinalpermeabilityinobesityrelatedsevereacutepancreatitis
AT zhending disruptingofigf2bp3stabilizedcldn11mrnabytnfaincreasesintestinalpermeabilityinobesityrelatedsevereacutepancreatitis